Science, Ethics, and Deception: A Study of Medications, Placebos, and Labeling in Acute Episodic Migraine
March 20, 2019
25 Shattuck Street
This month, Professor Ted Kaptchuk will present the results of a randomized control trial for patients with acute episodic migraines. The trial, conducted at the Beth Israel Deaconess Medical Center, provided a medication and an identical-appearing placebo intervention with the goal of assessing how medication labeling might modify their effects. In addition to raising familiar ethical issues around the use and study of placebos, this trial provoked significant ethical debate because it also involved deception.